AAAAAA

   
Results: 1-8 |
Results: 8
POSTCHOLECYSTECTOMY BILIARY LEAKS IN THE LAPAROSCOPIC ERA - RISK-FACTORS, PRESENTATION, AND MANAGEMENT
Authors: BARKUN AN REZIEG M MEHTA SN PAVONE E LANDRY S BARKUN JS FRIED GM BRET P COHEN A
Citation: An. Barkun et al., POSTCHOLECYSTECTOMY BILIARY LEAKS IN THE LAPAROSCOPIC ERA - RISK-FACTORS, PRESENTATION, AND MANAGEMENT, Gastrointestinal endoscopy, 45(3), 1997, pp. 277-282
3 DIFFERENT GB-VIRUS-C HEPATITIS-G-VIRUS GENOTYPES - PHYLOGENETIC ANALYSIS AND A GENOTYPING ASSAY BASED ON RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM
Authors: MUKAIDE M MIZOKAMI M ORITO E OHBA K NAKANO T UEDA R HIKIJI K IINO S SHAPIRO S LAHAT N PARK YM KIM BS OYUNSUREN T REZIEG M ALAHDAL MN LAU JYN
Citation: M. Mukaide et al., 3 DIFFERENT GB-VIRUS-C HEPATITIS-G-VIRUS GENOTYPES - PHYLOGENETIC ANALYSIS AND A GENOTYPING ASSAY BASED ON RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM, FEBS letters, 407(1), 1997, pp. 51-58
COMPARISON OF THE LONG-TERM TOLERABILITY, PHARMACODYNAMICS, AND SAFETY OF SANDIMMUNE AND NEORAL IN LIVER-TRANSPLANT RECIPIENTS
Authors: GRANT D ROCHON J LEVY G CATTRAL M CHEUNG S GRIEG P ALTRAIF I REZIEG M WONG PY ADAMS P ASFAR S FREEMAN D GHENT C WALL W
Citation: D. Grant et al., COMPARISON OF THE LONG-TERM TOLERABILITY, PHARMACODYNAMICS, AND SAFETY OF SANDIMMUNE AND NEORAL IN LIVER-TRANSPLANT RECIPIENTS, Transplantation proceedings, 28(4), 1996, pp. 2232-2233
CYCLOSPORINE NEORAL IN LIVER-TRANSPLANT RECIPIENTS
Authors: LEVY G ALTRAIF I REZIEG M ASFAR S ROCHON J FREEMAN D WONG PY BANKS L ROACH C ENGEL K GRANT D
Citation: G. Levy et al., CYCLOSPORINE NEORAL IN LIVER-TRANSPLANT RECIPIENTS, Transplantation proceedings, 26(6), 1994, pp. 3184-3187
LIVER-TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA
Authors: CHUNG SW TOTH JL REZIEG M CAMERON R TAYLOR BR GREIG PD LEVY GA LANGER B
Citation: Sw. Chung et al., LIVER-TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA, The American journal of surgery, 167(3), 1994, pp. 317-321
TREATMENT OF HEPATITIS-C VIRAL-INFECTION (HCV) IN THE TRANSPLANTED PATIENT WITH RIBAVARIN
Authors: REZIEG M ALTRAIF I ROACH C GREIG P COLE E KRAJDEN M LEVY G
Citation: M. Rezieg et al., TREATMENT OF HEPATITIS-C VIRAL-INFECTION (HCV) IN THE TRANSPLANTED PATIENT WITH RIBAVARIN, Hepatology, 18(4), 1993, pp. 10000342-10000342
TREATMENT OF CHRONIC HEPATITIS-C VIRAL-INFECTION (HCV) IN THE TRANSPLANTED PATIENT
Authors: REZIEG M ALTRAIF I ROACH C GREIG P COLE E KRAJDEN M LEVY G
Citation: M. Rezieg et al., TREATMENT OF CHRONIC HEPATITIS-C VIRAL-INFECTION (HCV) IN THE TRANSPLANTED PATIENT, Hepatology, 18(3), 1993, pp. 739-739
THE MANAGEMENT OF BILE LEAKS IN THE ERA OF LAPAROSCOPIC CHOLECYSTECTOMY
Authors: REZIEG M BARKUN JS BARKUN AN
Citation: M. Rezieg et al., THE MANAGEMENT OF BILE LEAKS IN THE ERA OF LAPAROSCOPIC CHOLECYSTECTOMY, Gastrointestinal endoscopy, 39(2), 1993, pp. 330-330
Risultati: 1-8 |